N-(4-Fluorobenzyl)-3-hydroxy-9,9-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a]pyrimidine-2-carboxamides a novel class of potent HIV-1 integrase inhibitors
- 1 August 2009
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (15), 4245-4249
- https://doi.org/10.1016/j.bmcl.2009.05.098
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- 3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates—fast access to a heterocyclic scaffold for HIV-1 integrase inhibitorsTetrahedron Letters, 2008
- Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS InfectionJournal of Medicinal Chemistry, 2008
- Design and Synthesis of Bicyclic Pyrimidinones as Potent and Orally Bioavailable HIV-1 Integrase InhibitorsJournal of Medicinal Chemistry, 2008
- Dihydroxypyrimidine-4-carboxamides as Novel Potent and Selective HIV Integrase InhibitorsJournal of Medicinal Chemistry, 2007
- Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected CellsJournal of Medicinal Chemistry, 2003
- L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.Proceedings of the National Academy of Sciences of the United States of America, 1994